For late April 2026, the most anticipated debut is , which is set to list on the NYSE on April 29, 2026 with a massive $5 billion offering. Other notable upcoming or newly listed stocks include Avalyn Pharma (AVLN) and Seaport Therapeutics (SPTX) , both targeting biotech breakthroughs in respiratory and neuropsychiatric care. Immediate IPO Listings (Late April - Early May 2026)
: A $20 billion market cap asset manager listing on the NYSE. The IPO is bundled with a closed-end fund, Pershing Square USA, Ltd. (PSUS) . new ipo stocks to buy
: Since its April 16 debut, the stock has climbed 53.6% . For late April 2026, the most anticipated debut
: This mid-April biotech listing is up 48.9% from its offer price. Blockbuster Candidates for Later in 2026 The IPO is bundled with a closed-end fund,
: A clinical-stage biopharmaceutical firm focusing on inhaled therapies for rare lung diseases. Expected listing on April 30, 2026 , on the NASDAQ.